Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Nov 27.
doi: 10.1007/s40264-025-01625-7. Online ahead of print.

Systematic Review of Active Safety Surveillance of Vaccines and Medicines in Low- and Middle-Income Countries

Affiliations

Systematic Review of Active Safety Surveillance of Vaccines and Medicines in Low- and Middle-Income Countries

Andy Stergachis et al. Drug Saf. .

Abstract

Background: Functional active safety surveillance is essential for post-authorization assessment and life-cycle safety evidence generation of vaccines and medicines. Data collected through active surveillance methods are routinely used for post-approval surveillance of novel vaccines and medicines. Implementing these methods in low- and middle-income countries remains challenging.

Objective: This systematic review identified and assessed existing active safety surveillance in low- and middle-income countries, including key features, strengths, and limitations.

Methods: A search of EMBASE and PubMed Google Scholar databases was conducted. The protocol was registered with PROSPERO and adhered to Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) guidelines. Findings were synthesized narratively and categorized by surveillance systems characteristics.

Results: Of 13,027 records identified, 423 publications met inclusion criteria. Articles spanned 96 low- and middle-income countries, with India (96), China (57), Brazil (30), Iran (26), Ethiopia (21), Indonesia (20), Uganda (18), Kenya (17), and Ghana (16), most represented. The majority focused on vaccines (211). A total of 127 articles utilized mobile technologies for follow-up, online data collection, and/or adverse event reporting. Fifteen percent of vaccine surveillance systems described in articles demonstrated flexibility to incorporate new vaccines, 34% reported multi-sectoral collaborations, and 10% involved multiple countries. Gaps identified include small sample sizes, lack of sustainability, limited flexible surveillance, staffing challenges, and limited use of standard case definitions and digital technologies.

Conclusions: Active safety surveillance in low- and middle-income countries has made progress but still faces challenges. The capture and management of safety data through harmonized digital tools that promote consistency in recording and reporting and cross-country collaborations are crucial in further strengthening active safety surveillance in low- and middle-income countries.

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflicts of Interest/Competing Interests: Andy Stergachis, Esperança Sevene, Mohammad Gazi Shah Alam, Rebecca E Chandler, Alexander Precioso, Samatha Mudigonda, Dale Nordenberg, and Robert T. Chen have no conflicts of interest that are directly relevant to the content of this article. Ethics Approval: This study reviews articles conducted with human participants. However, as it does not include identifiable information and is based on previously published data, it is exempt from requiring ethical approval. Consent to Participate: Not applicable. Consent for Publication: Not applicable. Availability of Data and Material: All data generated and analyzed in this study are available within this published article and its electronic supplementary material. Data can also be accessed through a dashboard available at https://active-surveillance.speacsafety.net/description . Code Availability: The data extraction form can be provided by the corresponding author upon reasonable request.

References

    1. Kochhar S, Izurieta HS, Chandler RE, Hacker A, Chen RT, Levitan B. Benefit-risk assessment of vaccines. Vaccine. 2024;42(4):969–71. - DOI - PubMed
    1. Council for International Organizations of Medical Sciences. CIOMS guide to active vaccine safety surveillance. Available from: https://cioms.ch/publications/product/cioms-guide-to-active-vaccine-safe... . Accessed 11 Nov 2025.
    1. Black S. The importance of active surveillance in the assessment of vaccine safety. China CDC Wkly. 2019;1(2):26–7. - DOI - PubMed - PMC
    1. Buttery JP, Clothier H. Information systems for vaccine safety surveillance. Hum Vaccin Immunother. 2022;18(6):2100173. - DOI - PubMed - PMC
    1. Crawford NW, Clothier H, Hodgson K, Selvaraj G, Easton ML, Buttery JP. Active surveillance for adverse events following immunization. Expert Rev Vaccines. 2014;13(2):265–76. - DOI - PubMed

Publication types

LinkOut - more resources